EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

Clinical trial NCT07047703 · RECRUITING

Trial details

NCT number: NCT07047703
Sponsor: Grey Wolf Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Axial Spondyloarthritis (AxSpA)

Start date: 2025-07-28
Primary completion: 2028-04-30
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.